Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis

The discovery of metabolite-phenotype associations may highlight candidate biomarkers and metabolic pathways altered in disease states. We sought to identify novel metabolites associated with obesity and one of its major complications, nonalcoholic fatty liver disease (NAFLD), using a liquid chromat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCI Insight
Asıl Yazarlar: Kimberly, W. Taylor, O’Sullivan, John F., Nath, Anjali K., Keyes, Michelle, Shi, Xu, Larson, Martin G., Yang, Qiong, Long, Michelle T., Vasan, Ramachandran, Peterson, Randall T., Wang, Thomas J., Corey, Kathleen E., Gerszten, Robert E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414569/
https://ncbi.nlm.nih.gov/pubmed/28469090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.92989
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller